167 filings
Page 3 of 9
8-K
0rracx
27 Dec 17
Submission of Matters to a Vote of Security Holders
12:00am
8-K/A
67ve0vm3ulaifbsp
6 Dec 17
Financial Statements and Exhibits
12:00am
8-K/A
e7dvcj3 ce38u1i4ctbx
5 Dec 17
Report of Independent Registered Public Accounting Firm
12:00am
8-K
1xd42cho7h
4 Dec 17
Important Information and Where to Find It
12:00am
8-K
z67zhnc
1 Dec 17
Entry into a Material Definitive Agreement
12:00am
8-K
mbutk12 sfsvjts13
29 Nov 17
Melinta Therapeutics Enters Into Agreement to Acquire Infectious Disease
12:00am
8-K
da667w z1t986sz
9 Nov 17
Changes in Registrant's Certifying Accountant
12:00am
8-K
dqcwjsti7hyj f0
3 Nov 17
Cempra Announces Preliminary Results of 2017 Stockholder Vote
12:00am
8-K
oacqmh2
1 Nov 17
Melinta and Cempra Announce Accomplished Executive Leadership Team for Combined Organization
12:00am
8-K
v14g7if6iac73v5g4b2
31 Oct 17
Other Events
12:00am
8-K
hy0ds63qn5
28 Sep 17
Rodino Waiting Period for Proposed Merger
12:00am
8-K
1hfdkwm59fjs79ap
11 Sep 17
JOINING FORCES TO CREATE A LEADING COMMERCIAL-STAGE COMPANY Focused on Anti-Infectives September 2017
12:00am
8-K
063y60vatn 3e
7 Sep 17
Cempra Announces Presentations at Upcoming Investor
12:00am
8-K
zb4s k98f3xn
10 Aug 17
Cempra and Melinta Announce Merger to Form
12:00am
8-K
meu7dwf1w 9ydu417kh
9 Aug 17
Cempra Provides Corporate Update and Reports Second Quarter 2017 Financial Results
12:00am
8-K
7seylvtkzg f9oot8n4
28 Jun 17
Departure of Directors or Certain Officers
12:00am
8-K
f4k7cz0izgk2t2b
28 Apr 17
Cempra Reports First Quarter 2017 Financial Results and Provides Corporate Update
12:00am
8-K
hq64yd2qhrrzhn
28 Apr 17
Departure of Directors or Certain Officers
12:00am
8-K
amqd43 jhm8x
28 Mar 17
Other Events
12:00am
8-K
ytk60 8h3qa3
13 Mar 17
Cempra Retains Morgan Stanley to Lead Review of Strategic Business Options
12:00am